-
B647923-5mgBMS-433771 is a potent orally active inhibitor of respiratory syncytial virus (RSV) . BMS-433771 is active against both A and B groups of RSV , with an average EC 50 of 20 nM. BMS-433771 can be used for the research of respiratory tract diseaseIn
-
B650030-10mgBMS-433771 dihydrochloride hydrate is a potent orally active inhibitor of respiratory syncytial virus (RSV) . BMS-433771 dihydrochloride hydrate is active against both A and B groups of RSV , with an average EC 50 of 20 nM. BMS-433771
-
B650030-25mgBMS-433771 dihydrochloride hydrate is a potent orally active inhibitor of respiratory syncytial virus (RSV) . BMS-433771 dihydrochloride hydrate is active against both A and B groups of RSV , with an average EC 50 of 20 nM. BMS-433771
-
B650030-5mgBMS-433771 dihydrochloride hydrate is a potent orally active inhibitor of respiratory syncytial virus (RSV) . BMS-433771 dihydrochloride hydrate is active against both A and B groups of RSV , with an average EC 50 of 20 nM. BMS-433771
-
B649850-100mgBMS-582949 hydrochloride is an orally active and highly selective p38α MAPK inhibitor, with an IC 50 of 13 nM. BMS-582949 hydrochloride displays a significantly improved pharmacokinetic profile and is effective in inflammatory diseaseIn
-
B649850-10mgBMS-582949 hydrochloride is an orally active and highly selective p38α MAPK inhibitor, with an IC 50 of 13 nM. BMS-582949 hydrochloride displays a significantly improved pharmacokinetic profile and is effective in inflammatory diseaseIn
-
B649850-25mgBMS-582949 hydrochloride is an orally active and highly selective p38α MAPK inhibitor, with an IC 50 of 13 nM. BMS-582949 hydrochloride displays a significantly improved pharmacokinetic profile and is effective in inflammatory diseaseIn
-
B649850-50mgBMS-582949 hydrochloride is an orally active and highly selective p38α MAPK inhibitor, with an IC 50 of 13 nM. BMS-582949 hydrochloride displays a significantly improved pharmacokinetic profile and is effective in inflammatory diseaseIn
-
B649850-5mgBMS-582949 hydrochloride is an orally active and highly selective p38α MAPK inhibitor, with an IC 50 of 13 nM. BMS-582949 hydrochloride displays a significantly improved pharmacokinetic profile and is effective in inflammatory diseaseIn
-
B656025-1mlBMS-582949 hydrochloride is an orally active and highly selective p38α MAPK inhibitor, with an IC 50 of 13 nM. BMS-582949 hydrochloride displays a significantly improved pharmacokinetic profile and is effective in inflammatory diseaseIn
-
B651972-10mgBMS-770767 is an 11β-hydroxysteroid dehydrogenase 1 ( 11β-HSD1 ) inhibitor in type 2 diabetes. 11β-HSD1 is an important enzyme that is widely expressed in liver, adipose tissue and other tissues and plays an important role in metabolic diseases such
-
B651972-25mgBMS-770767 is an 11β-hydroxysteroid dehydrogenase 1 ( 11β-HSD1 ) inhibitor in type 2 diabetes. 11β-HSD1 is an important enzyme that is widely expressed in liver, adipose tissue and other tissues and plays an important role in metabolic diseases such